JINXIN FERTILITY GROUP LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.86 HKD | +3.62% |
|
+0.35% | -14.63% |
| Jun. 25 | Jinxin Fertility Group Limited Approves Final Dividend for the Year Ended December 31, 2023 | CI |
| Mar. 29 | Jinxin Fertility Logs 185% Profit Surge in 2023 as Revenue Rises 18% | MT |
Jinxin Fertility Group Ltd is an investment holding company principally engaged in the provision of in-vitro fertilization (IVF) services. Through its subsidiaries, the Company mainly provides assisted reproductive services, management services, ambulatory surgery center facilities services, ancillary medical services, obstetrics, gynecology and pediatrics medical services, as well as the sales of medical consumables and equipment. The Company mainly provides its services in both China and the United States.
Calendar
2024-08-26
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
2.656
CNY
Average target price
4.565
CNY
Spread / Average Target
+71.90%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -14.63% | 1.01B | |
| +19.84% | 84.94B | |
| -25.24% | 74.07B | |
| -1.34% | 26.15B | |
| +4.56% | 18.03B | |
| -9.29% | 17.38B | |
| +4.52% | 16.01B | |
| +78.16% | 13.7B | |
| +77.84% | 13.13B | |
| -26.14% | 12.74B |
- Stock Market
- Equities
- 1951 Stock
- News Jinxin Fertility Group Limited
- Nomura Adjusts Jinxin Fertility’s Price Target to HK$8.90 From HK$8.71, Keeps at Buy
